To explore the expression pattern of WDR6, in the present study, we first analyzed the data of the Oncomine database, and the results showed that compared with corresponding normal tissues, the expression of WDR6 was decreased in breast and kidney cancer, but was increased in brain and CNS cancer, colorectal cancer, myeloma, and sarcoma (Figure 1A). The gene discussed is WDR6; the disease is central nervous system cancer.